Dr. Birgit Schoeberl is an internationally recognized leader in the application of Systems Biology to biology and drug development. At Merrimack, she leads early stage drug discovery and development programs. She joined Merrimack Pharmaceuticals in 2003 after doing postdoctoral training at MIT where she built some of the earliest computational models of signaling networks. Dr. Schoeberl holds an M.S. in chemical engineering from the University of Karlsruhe, Germany, and a Ph.D. from the Max-Planck-Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany.